Concurrent Prophylactic Mastectomy,Immediate Reconstruction,and Salpingo-Oophorectomy in High-Risk Patients: A Case Series

Abstract

French

Purpose:

There are limited data on coordinated breast and gynecological risk-reduction surgery for high-risk patients in Canada. Therefore, this study aims to evaluate the patient demographics, surgical details, and outcomes of prophylactic mastectomy (PM) with immediate reconstruction and bilateral salpingo-oophorectomy (BSO) in high-risk patients.

Methods:

We conducted a retrospective chart review at an academic center of patients who concurrently underwent PM with immediate reconstruction and laparoscopic BSO over a 7-year period (March 2010-February 2017) were identified.

Results:

A total of 16 patients underwent PM with immediate reconstruction and concurrent BSO. The mean age at the time of surgery was 46.2 ± 6.6 years. Thirteen (81%) patients were carriers of the BRCA1 or BRCA2 mutation. Two patients had prophylactic surgical therapy for BRCA1 mutation and 14 (87.5%) patients had prior oncological treatment. The most common type of procedures performed were skin-sparing, nipple-sparing mastectomy (56.2%) and reconstruction with acellular dermal matrix and implants (43.8%). All patients underwent laparoscopic BSO. The average combined case time was 282.5 ± 81.3 minutes with an average postoperative hospital stay of 1.3 ± 0.5 days. Six (37.5%) patients presented with 30-day postoperative complications, with higher rates in the alloplastic group. There were no gynecological complications.

Conclusions:

In conclusion, our results demonstrate that a combined multidisciplinary surgical approach did not increase length of stay or 30-day complication rates. Furthermore, concurrent risk-reducing strategies are an effective option for patients at high risk of breast or ovarian cancer.

Keywords

BRCA breast cancer breast reconstruction risk-reduction surgery

Get full access to this article

View all access options for this article.

References

Jemal

Siegel

Ward

, et al. Cancer Statistics, 2008. CA Cancer J Clin. 2008;58(2):71–96.

Dowdy

Stefanek

Hartmann

. Surgical risk reduction: Prophylactic salpingo-oophorectomy and prophylactic mastectomy. Am J Obstet Gynecol. 2004;191(4):1113–1123.

King

M-C

Marks

Mandell

, et al. New York Breast Cancer Study Group. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science. 2003;302(5645):643–646.

Petrucelli

Daly

Feldman

. Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2. Genet Med. 2010;12(5):245–259.

Goldberg

Borgen

. Breast cancer susceptibility testing: past, present and future. Expert Rev Anticancer Ther. 2006;6(8):1205–1214.

Burke

Daly

Garber

, et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. JAMA. 1997;277(12):997–1003.

Meijers-Heijboer

van Geel

van Putten

, et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med. 2001;345(3):159–164.

Hartmann

Schaid

Woods

, et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med. 1999;340(2):77–84.

Rebbeck

Lynch

Neuhausen

, et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med. 2002;346(21):1616–1622.

10.

Domchek

Friebel

Singer

, et al. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA. 2010;304(9):967–975.

11.

Gray

Wasif

, et al. Outcomes of concurrent breast and gynecologic risk reduction surgery. Ann Surg Oncol. 2017;24(1):77–83. doi:10.1245/s10434-016-5479-6.

12.

Easton

Ford

Bishop

. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast cancer linkage consortium. Am J Hum Genet. 1995;56(1):265–271.

13.

Schrag

Kuntz

Garber

Weeks

. Benefit of prophylactic mastectomy for women with BRCA1 or BRCA2 mutations. JAMA. 2000;283(23):3070–3072.

14.

Baxter

Goel

Semple

. Utilization and regional variation of breast reconstruction in Canada. Plast Reconstr Surg. 2005;115(1):338–339.

15.

Barnsley

Sigurdson

Kirkland

. Barriers to breast reconstruction after mastectomy in Nova Scotia. Can J Surg. 2008;51(6):447–452.

16.

Morrow

Alderman

, et al. Access to breast reconstruction after mastectomy and patient perspectives on reconstruction decision making. JAMA Surg. 2014;149(10):1015–1021.

17.

Platt

Baxter

Zhong

. Breast reconstruction after mastectomy for breast cancer. CMAJ. 2011;183(18):2109–2116.

18.

Ilonzo

Tsang

Tsantes

Estabrook

Thu Ma

. Breast reconstruction after mastectomy: A ten-year analysis of trends and immediate postoperative outcomes. Breast. 2017;32:7–12.

19.

Norum

Hagen

Maehle

Apold

Burn

Møller

. Prophylactic bilateral salpingo-oophorectomy (PBSO) with or without prophylactic bilateral mastectomy (PBM) or no intervention in BRCA1 mutation carriers: a cost-effectiveness analysis. Eur J Cancer. 2008;44(7):963–971.

20.

Elmi

Azin

Elnahas

McCready

Cil

. Concurrent risk-reduction surgery in patients with increased lifetime risk for breast and ovarian cancer: an analysis of the National Surgical Quality Improvement Program (NSQIP) database. Breast Cancer Res Treat. 2018;171(1):217–223.

21.

Willsher

Ali

Jackson

. Laparoscopic oophorectomy in the management of breast disease. ANZ J Surg. 2008;78(8):670–672. doi:10.1111/j.1445-2197.2008.04614.x.

22.

Casey

Rebecca

Andres

, et al. Safety and efficacy of perforator flap breast reconstruction with combined intraabdominal procedures. Ann Plast Surg. 2010;64(2):144–150.

23.

Perabò

Fink

Günthner-Biller

Von Bodungen

Friese

Dian

. Prophylactic mastectomy with immediate reconstruction combined with simultaneous laparoscopic salpingo-oophorectomy via a transmammary route: A novel surgical approach to female BRCA-mutation carriers. Arch Gynecol Obstet. 2014;289(6):1325–1330.

24.

Batista

Beahm

Arun

Bodurka

Meric-Bernstam

. Coordinated prophylactic surgical management for women with hereditary breast-ovarian cancer syndrome. BMC Cancer. 2008;8:101.

25.

Del Corral

Wes

Fischer

Serletti

. Outcomes and cost analysis in high-risk patients undergoing simultaneous free flap breast reconstruction and gynecologic procedures. Ann Plast Surg. 2015;75(5):534–538.

26.

Voss

Sharp

Scott

. Abdominoplasty combined with gynecologic surgical procedures. Obstet Gynecol. 1986;67(2):181–185.